NIH discovery in mice could lead to new class of medications to fight mid-life obesity

Researchers led and partly funded by NHLBI have identified an enzyme that could help in the continuous battle against mid-life obesity and fitness loss. Reported in Cell Metabolism, the discovery in mice could upend current notions about why people gain weight as they age, and could one day lead to more effective weight-loss medications.   

UPI: Inhibiting an enzyme could help prevent weight gain, researchers say 

U.S. News & World Report: Is this enzyme making you fat?

Voice of America news:  Mid-life Obesity: There Might Be a Pill for That  

Medical News Today: Inhibiting key enzyme may prevent midlife weight gain 

Live Science: Gaining Weight In Middle Age? It's This Molecule's Fault, Scientists Say

NIH: NIH discovery in mice could lead to new class of medications to fight mid-life obesity

Prensa Latina: Study Shows Inhibition of an Enzyme can Prevent Weight Gain 

BioWorld: Culprit behind aging-obesity paradox identified

NIH Research Matters: Enzyme drives middle-age weight and fitness changes